Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease
AbstractAlzheimer’s disease (AD), characterized by cognitive decline and devastating neurodegeneration, is the most common age-related dementia. Since AD is a typical example of a complex disease that is affected by various genetic and environmental factors, various factors could be involved in preventing and/or treating AD. Extracellular accumulation of beta-amyloid peptide (Aβ) and intracellular accumulation of tau undeniably play essential roles in the etiology of AD. However, interestingly enough, medications targeting Aβ or tau all failed and the only clinically efficient medications for AD are drugs targeting the cholinergic pathway. Also, a very intriguing discovery in AD is that the Mediterranean diet (MeDi), containing an unusually large quantity of Lactobacilli, is very effective in preventing AD. Based on recently emerging findings, it is our opinion that the reduction of blood ammonia levels by Lactobacilli in MeDi is the therapeutic agent of MeDi for AD. The recent evidence of Lactobacilli lowering blood ammonia level not only provides a link between AD and MeDi but also provides a foundation of pharmabiotics for hyperammonemia as well as various neurological diseases. View Full-Text
Share & Cite This Article
Jin, Y.Y.; Singh, P.; Chung, H.-J.; Hong, S.-T. Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease. Nutrients 2018, 10, 564.
Jin YY, Singh P, Chung H-J, Hong S-T. Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease. Nutrients. 2018; 10(5):564.Chicago/Turabian Style
Jin, Yan Y.; Singh, Parul; Chung, Hea-Jong; Hong, Seong-Tschool. 2018. "Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease." Nutrients 10, no. 5: 564.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.